No Data
JINHAI MED TECH: Annual Report 2024
Market Participants Recognise Jinhai Medical Technology Limited's (HKG:2225) Revenues
JINHAI MED TECH: ANNOUNCEMENT OF ANNUAL RESULTSFOR THE YEAR ENDED 31 DECEMBER 2024
JINHAI MED TECH (02225.HK) expects an annual loss of approximately 18.1 million Singapore dollars.
On March 21, GELONGHUI reported that JINHAI MED TECH (02225.HK) announced the group is expected to record a net loss of approximately 18.1 million Singapore dollars for the year ending December 31, 2024, compared to a net loss of about 4.1 million Singapore dollars in the previous year. The Board of Directors believes the group's Business will show stable development in the fiscal year 2024. The group expects to achieve revenue of approximately 50.2 million Singapore dollars and a gross profit of about 11.4 million Singapore dollars for the fiscal year 2024, whereas the revenue for the fiscal year 2023 was about 45.6 million Singapore dollars and gross profit was approximately 12 million Singapore dollars.
Jinhai Medical Technology Issues Profit Warning Amid Rising Expenses
JINHAI MED TECH: PROFIT WARNING
There's Reason For Concern Over Jinhai Medical Technology Limited's (HKG:2225) Massive 31% Price Jump
